Racial and Ethnic Disparities in the Diagnosis and Treatment of Psoriasis

Andrew Alexis, MD, MPH


February 23, 2022

Andrew Alexis, MD, MPH, considers the underrepresentation of psoriasis in specific racial and ethnic populations, both in terms of presence in clinical trials and inclusion in clinical tools that facilitate timely diagnosis and treatment. Although there are currently major efforts in place to overcome these disparities, Dr Alexis notes that there is still much to do in order to correct these imbalances.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.